BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Misra P, Blancas-Mejia LM, Ramirez-Alvarado M. Mechanistic Insights into the Early Events in the Aggregation of Immunoglobulin Light Chains. Biochemistry 2019;58:3155-68. [PMID: 31287666 DOI: 10.1021/acs.biochem.9b00311] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Absmeier RM, Rottenaicher GJ, Svilenov HL, Kazman P, Buchner J. Antibodies gone bad - the molecular mechanism of light chain amyloidosis. FEBS J 2023;290:1398-419. [PMID: 35122394 DOI: 10.1111/febs.16390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Riefolo M, Conti M, Longhi S, Fabbrizio B, Leone O. Amyloidosis: What does pathology offer? The evolving field of tissue biopsy. Front Cardiovasc Med 2022;9:1081098. [PMID: 36545023 DOI: 10.3389/fcvm.2022.1081098] [Reference Citation Analysis]
3 Maya-Martinez R, Xu Y, Guthertz N, Walko M, Karamanos TK, Sobott F, Breeze AL, Radford SE. Dimers of D76N-β(2)-microglobulin display potent antiamyloid aggregation activity. J Biol Chem 2022;298:102659. [PMID: 36328246 DOI: 10.1016/j.jbc.2022.102659] [Reference Citation Analysis]
4 Fedotov SA, Khrabrova MS, Anpilova AO, Dobronravov VA, Rubel AA. Noninvasive Diagnostics of Renal Amyloidosis: Current State and Perspectives. Int J Mol Sci 2022;23:12662. [PMID: 36293523 DOI: 10.3390/ijms232012662] [Reference Citation Analysis]
5 Ikura H, Endo J, Kitakata H, Moriyama H, Sano M, Fukuda K. Molecular Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis. IJMS 2022;23:6336. [DOI: 10.3390/ijms23116336] [Reference Citation Analysis]
6 Lavatelli F. Mechanisms of Organ Damage and Novel Treatment Targets in AL Amyloidosis. Hemato 2022;3:47-62. [DOI: 10.3390/hemato3010005] [Reference Citation Analysis]
7 Elmoamly S, Obici L. Amyloidosis: Pathogenesis, Types, and Diagnosis. Paraproteinemia and Related Disorders 2022. [DOI: 10.1007/978-3-031-10131-1_7] [Reference Citation Analysis]
8 Lizoń A, Tisończyk J, Gajewska M, Drożdż R. Silver Nanoparticles as a Tool for the Study of Spontaneous Aggregation of Immunoglobulin Monoclonal Free Light Chains. Int J Mol Sci 2021;22:9703. [PMID: 34575867 DOI: 10.3390/ijms22189703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Misra P, Ramirez-Alvarado M. Early events in light chain aggregation at physiological pH reveal new insights on assembly, stability, and aggregate dissociation. Amyloid 2021;28:113-24. [PMID: 33533277 DOI: 10.1080/13506129.2021.1877129] [Reference Citation Analysis]
10 Dispenzieri A, Merlini G. Future Perspectives. Hematol Oncol Clin North Am 2020;34:1205-14. [PMID: 33099434 DOI: 10.1016/j.hoc.2020.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Griffin JM, Rosenblum H, Maurer MS. Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis. Circ Res 2021;128:1554-75. [PMID: 33983835 DOI: 10.1161/CIRCRESAHA.121.318187] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
12 Evangelisti A, Butler H, Del Monte F. The Heart of the Alzheimer's: A Mindful View of Heart Disease. Front Physiol 2020;11:625974. [PMID: 33584340 DOI: 10.3389/fphys.2020.625974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Abe Y, Shibata H, Oyama K, Ueda T. Effect of O-glycosylation on amyloid fibril formation of the variable domain in the Vλ6 light chain mutant Wil. Int J Biol Macromol 2021;166:342-51. [PMID: 33127550 DOI: 10.1016/j.ijbiomac.2020.10.194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Pradhan T, Annamalai K, Sarkar R, Hegenbart U, Schönland S, Fändrich M, Reif B. Solid state NMR assignments of a human λ-III immunoglobulin light chain amyloid fibril. Biomol NMR Assign 2021;15:9-16. [PMID: 32946005 DOI: 10.1007/s12104-020-09975-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Picken MM. The Pathology of Amyloidosis in Classification: A Review. Acta Haematol 2020;143:322-34. [PMID: 32392555 DOI: 10.1159/000506696] [Cited by in Crossref: 59] [Cited by in F6Publishing: 70] [Article Influence: 19.7] [Reference Citation Analysis]